Routledge P A, Barchowsky A, Bjornsson T D, Kitchell B B, Shand D G
Clin Pharmacol Ther. 1980 Mar;27(3):347-51. doi: 10.1038/clpt.1980.46.
The percent of unbound lidocaine in the plasma of 24 healthy subjects was measured by equilibrium dialysis after addition of 3 microgram/ml C14 lidocaine hydrochloride. The percentage of unbound lidocaine varied from 19.9 to 38.8 (30.2 +/- 5, mean +/- SD) was inversely related to the concentration of alpha 1-acid glycoprotein (AAG) in the plasma (r = -0.931, p less than 0.001). The binding ratio (number of moles bound divided by number of moles unbound) of lidocaine was directly related to the plasma AAG concentration (r = 0.960, p less than 0.001). The binding ratio of lidocaine in solutions containing AAG but no albumin, prepared from the plasma of subjects in the study, was also directly related to the concentration of this acute-phase protein (r = 0.909, p less than 0.001). Human serum albumin solution (4 gm/100 ml) bound lidocaine to the extent of 20% under the same conditions. There was no relationship between the binding ratio of lidocaine and the albumin concentration in the plasma of the 24 subjects. In 7 normal subjects variation in AAG between 2 samples collected at least 1 mo apart was associated with a concomitant change in plasma lidocaine binding (r = 0.943, p less than 0.01). Thus even in normal subjects there is considerable interindividual and intraindividual variation in lidocaine binding, and measurements of AAG concentration in plasma may be a useful predictor of the extent of lidocaine plasma binding.
在24名健康受试者的血浆中加入3微克/毫升的C14盐酸利多卡因后,通过平衡透析法测定游离利多卡因的百分比。游离利多卡因的百分比在19.9%至38.8%之间变化(平均±标准差为30.2±5),与血浆中α1 - 酸性糖蛋白(AAG)的浓度呈负相关(r = -0.931,p<0.001)。利多卡因的结合率(结合的摩尔数除以未结合的摩尔数)与血浆AAG浓度呈正相关(r = 0.960,p<0.001)。从研究中的受试者血浆制备的不含白蛋白但含有AAG的溶液中,利多卡因的结合率也与这种急性期蛋白的浓度呈正相关(r = 0.909,p<0.001)。在相同条件下,人血清白蛋白溶液(4克/100毫升)使利多卡因的结合程度达到20%。在这24名受试者的血浆中,利多卡因的结合率与白蛋白浓度之间没有关系。在7名正常受试者中,至少相隔1个月采集的两份样本之间AAG的变化与血浆利多卡因结合的相应变化相关(r = 0.943,p<0.01)。因此,即使在正常受试者中,利多卡因的结合在个体间和个体内也存在相当大的差异,血浆中AAG浓度的测定可能是利多卡因血浆结合程度的一个有用预测指标。